Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > I Wonder

<< Previous

Bullboard Posts

Next >>

Comment by Gman620on Oct 22, 2021 5:13pm

263 Views

Post# 34039263

RE:RE:I Wonder

Infinity wrote: Tamarindo, That makes it two of us wondering if TLT management is fumbling with the Ball??

With a new CEO, and people that quit, I start wondering if anyone is managing the trials at the level needed to ensure results. You would at least expect a "new patient enrolled" message every now and then, or one of those 'we've added another clinic" happy news announcements.

It's way to quiet.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023